Among the sources of confusion accompanying the implementation of Medicare Part D is the distinction between drugs covered under Part B and Part D. CMS officials held a teleconference late in January to listen to provider concerns, answer questions, and correct misinterpretation.
Part B provides Supplementary Medical Insurance to Part A beneficiaries who enroll voluntarily and pay the monthly premium. In addition to physician and other outpatient services, Part B covers certain categories of drugs, including:
Confusion arises because some drugs can be paid by either Part B or Part D, depending upon the circumstances under which they are prescribed, dispensed, or administered. For example, total parenteral nutrition (TPN) solutions and their components are covered under Part B for a patient with permanent dysfunction of the gastrointestinal tract. But if the dysfunction is not permanent, a TPN solution is treated as a Part D drug. Medications like albuterol or insulin are payable under Part B when administered using DME such as a nebulizer or infusion pump; the drugs are covered by Part D if administered through a metered dose inhaler or a syringe.
In general, drugs dispensed by a physician, DME supplier, or hospital outpatient department will be covered by Part B. There are, however, exceptions. Part B does not cover patients in long-term care facilities; these patients are expected to receive coverage under Part D for all medically necessary drugs. Immunosuppressive agents are covered under Part B when an organ transplant is covered by Medicare, but the same drugs are to be billed to Part D for transplants that are not received under Medicare coverage. Vitamins and minerals added to TPN solutions are covered under Part B but cannot be billed with TPN solutions under Part D because vitamins and minerals are among those items specifically excluded from coverage by statute.
CMS expects the Part D plans to make a determination of coverage under Part B or D on a case-by-case basis. A prescription drug plan should not require that a Part B denial accompany claims for Part D coverage. Medicare Advantage plans that tell providers to process Part B drugs such as human growth factor under Part D are also mistaken in their interpretation of the coverage distinction.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.